Cargando…
Hyperthermic intrapleural chemotherapy: an update
The safety and efficacy of hyperthermic intrathoracic chemotherapy (HITHOC) as an adjunct to cytoreductive surgery (CRS) in pleural malignancies has been well demonstrated. This is most often described in cases of mesothelioma, thymoma, or other secondary pleural metastases. The utilization of a dir...
Autores principales: | Campany, Megan E., Reck dos Santos, Pedro A., Donato, Britton B., Alwardt, Cory M., Ernani, Vinicius, D’Cunha, Jonathan, Beamer, Staci E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10586986/ https://www.ncbi.nlm.nih.gov/pubmed/37868886 http://dx.doi.org/10.21037/jtd-23-454 |
Ejemplares similares
-
Abrupt hemodynamic changes accompanying intrapleural hyperthermic chemotherapy: Case series
por: Kim, Hyae-Jin, et al.
Publicado: (2018) -
Cytoreductive surgery combined with hyperthermic intrapleural chemotherapy to treat thymoma or thymic carcinoma with pleural dissemination
por: Yu, Lei, et al.
Publicado: (2013) -
Commentary: The anterior approach to Pancoast tumors: An oldie but a goodie
por: dos Santos, Pedro Reck, et al.
Publicado: (2021) -
Intraoperative support during lung transplantation
por: Reck dos Santos, Pedro, et al.
Publicado: (2021) -
Commentary: Seeing is believing: Addressing the technical challenges of preclinical models for lung transplantation
por: dos Santos, Pedro Reck, et al.
Publicado: (2022)